المؤلفون: Wang X; Department of Gynecological Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, 250117, P.R. China., Wu J; Department of Gynecological Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, 250117, P.R. China., Xie W; Department of Gynecology, The Second Hospital of Shandong University, Jinan, Shandong, 250033, P.R. China. xiewenli2009@163.com.

المصدر: Current treatment options in oncology [Curr Treat Options Oncol] 2024 Aug; Vol. 25 (8), pp. 1055-1062. Date of Electronic Publication: 2024 Jul 25.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Current Science, Inc Country of Publication: United States NLM ID: 100900946 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-6277 (Electronic) Linking ISSN: 15346277 NLM ISO Abbreviation: Curr Treat Options Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Gestational Trophoblastic Disease*/therapy , Gestational Trophoblastic Disease*/drug therapy , Molecular Targeted Therapy*/methods , Immunotherapy*/methods , Disease Management*, Humans ; Female ; Pregnancy ; Combined Modality Therapy/methods ; Combined Modality Therapy/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Treatment Outcome

المؤلفون: Liu P; School of Life Sciences, Jiangsu University, Zhenjiang, Jiangsu 212013, PR China., Shi C; School of Life Sciences, Jiangsu University, Zhenjiang, Jiangsu 212013, PR China., Qiu L; School of Life Sciences, Jiangsu University, Zhenjiang, Jiangsu 212013, PR China., Shang D; School of Life Sciences, Jiangsu University, Zhenjiang, Jiangsu 212013, PR China., Lu Z; School of Life Sciences, Jiangsu University, Zhenjiang, Jiangsu 212013, PR China., Tu Z; School of Life Sciences, Jiangsu University, Zhenjiang, Jiangsu 212013, PR China., Liu H; School of Pharmacy, Jiangsu University, Zhenjiang, Jiangsu 212013, PR China. Electronic address: hanqing@ujs.edu.cn.

المصدر: Current problems in cancer [Curr Probl Cancer] 2024 Aug; Vol. 51, pp. 101118. Date of Electronic Publication: 2024 Jul 04.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Mosby Country of Publication: United States NLM ID: 7702986 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-6345 (Electronic) Linking ISSN: 01470272 NLM ISO Abbreviation: Curr Probl Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/pathology , Breast Neoplasms*/metabolism , Breast Neoplasms*/drug therapy , Breast Neoplasms*/genetics , Proto-Oncogene Proteins*/metabolism , Proto-Oncogene Proteins*/genetics , Signal Transduction*/drug effects , Molecular Targeted Therapy*/methods, Humans ; Female ; Antineoplastic Agents/therapeutic use ; Antineoplastic Agents/pharmacology ; Gene Expression Regulation, Neoplastic/drug effects ; Animals

المؤلفون: Kumar Kore R; Department of Pharmacy, Guru Ghasidas University, Bilaspur, Chhattisgarh, India., Shirbhate E; Department of Pharmacy, Guru Ghasidas University, Bilaspur, Chhattisgarh, India., Singh V; Department of Pharmacy, Guru Ghasidas University, Bilaspur, Chhattisgarh, India., Mishra A; Department of Pharmacy, Guru Ghasidas University, Bilaspur, Chhattisgarh, India., Veerasamy R; Faculty of Pharmacy, AIMST University, Bedong, Kedah Darul Aman, Malaysia., Rajak H; Department of Pharmacy, Guru Ghasidas University, Bilaspur, Chhattisgarh, India.

المصدر: Cancer investigation [Cancer Invest] 2024 Aug; Vol. 42 (7), pp. 627-642. Date of Electronic Publication: 2024 Jul 05.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 8307154 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-4192 (Electronic) Linking ISSN: 07357907 NLM ISO Abbreviation: Cancer Invest Subsets: MEDLINE

مواضيع طبية MeSH: Uterine Cervical Neoplasms*/drug therapy , Uterine Cervical Neoplasms*/genetics , Molecular Targeted Therapy*/methods , Drugs, Investigational*/therapeutic use, Humans ; Female ; Antineoplastic Agents/therapeutic use ; ErbB Receptors/antagonists & inhibitors ; ErbB Receptors/genetics ; Signal Transduction/drug effects

المؤلفون: Duenas-Gonzalez A; Departamento de Medicina Genómica y Toxicología Ambiental, Instituto de Investigaciones Biomédicas UNAM, Mexico City, Mexico.; Subdireccion de Investigación Básica, Instituto Nacional de Cancerología, Mexico City, Mexico., Gonzalez-Fierro A; Subdireccion de Investigación Básica, Instituto Nacional de Cancerología, Mexico City, Mexico., Bornstein-Quevedo L; Immunohistochemistry and Molecular Biology Laboratory, InmunoQ, Mexico City, Mexico., Gutierrez-Delgado F; Centro de Estudios y Prevención del Cancer Tuxtla Gutiérrez, Chiapas, México; Latin American School of Oncology (ELO), México City, Mexico., Kast RE; Head of Faculty, Brain Study, IIAIG Study Center, Burlington, VT, USA., Chavez-Blanco A; Subdireccion de Investigación Básica, Instituto Nacional de Cancerología, Mexico City, Mexico., Dominguez-Gomez G; Subdireccion de Investigación Básica, Instituto Nacional de Cancerología, Mexico City, Mexico., Candelaria M; Departamento de Hematología, Instituto Nacional de Cancerología, Mexico City, Mexico., Romo-Pérez A; Instituto de Química, Universidad Nacional Autónoma de México, Mexico City, Mexico., Correa-Basurto J; Laboratorio de Diseño y Desarrollo de Nuevos Fármacos e Innovación Biotecnológica, SEPI-ESM, Instituto Politécnico Nacional, México, Mexico City, Mexico., Lizano M; Departamento de Medicina Genómica y Toxicología Ambiental, Instituto de Investigaciones Biomédicas UNAM, Mexico City, Mexico.; Subdireccion de Investigación Básica, Instituto Nacional de Cancerología, Mexico City, Mexico., Perez-de la Cruz V; Neurobiochemistry and Behavior Laboratory, National Institute of Neurology and Neurosurgery 'Manuel Velasco Suárez', Mexico City, Mexico., Robles-Bañuelos B; Subdireccion de Investigación Básica, Instituto Nacional de Cancerología, Mexico City, Mexico., Nuñez-Corona D; Subdireccion de Investigación Básica, Instituto Nacional de Cancerología, Mexico City, Mexico., Martinez-Perez E; Subdireccion de Investigación Básica, Instituto Nacional de Cancerología, Mexico City, Mexico., Verastegui E; Departamento de Cuidados Paliativos, Division de Cirugia, Instituto Nacional de Cancerologia, Mexico City, Mexico.

المصدر: Expert review of anticancer therapy [Expert Rev Anticancer Ther] 2024 Aug; Vol. 24 (8), pp. 665-677. Date of Electronic Publication: 2024 Jul 08.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101123358 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8328 (Electronic) Linking ISSN: 14737140 NLM ISO Abbreviation: Expert Rev Anticancer Ther Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms*/drug therapy , Neoplasms*/pathology , Antineoplastic Agents*/pharmacology , Antineoplastic Agents*/administration & dosage , Antineoplastic Agents*/adverse effects , Drug Repositioning* , Molecular Targeted Therapy*, Humans ; Animals ; Survival Rate ; Polypharmacology ; Drug Development

المؤلفون: Villa A; Miami Cancer Institute, Baptist Health South Florida, Oral Medicine, Oral Oncology and Dentistry, Miami, FL, 33176, USA. Alessandro.Villa@baptisthealth.net.; Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA. Alessandro.Villa@baptisthealth.net., Epstein JB; CA City of Hope National Medical Center, Oral Medicine Services, Duarte, CA, USA., Yarom N; Oral Medicine Unit, Sheba Medical Center, Tel Hashomer, Israel.; The Maurice Gabriela Goldschleger School of Dental Medicine, Faculty of Health and Medical Sciences, Tel Aviv University, Tel Hashomer Tel Aviv, Israel., Hong C; Discipline of Orthodontics and Paediatric Dentistry, Faculty of Dentistry National University of Singapore, Singapore, Singapore., Fulop C; Division of Dentistry, The Ottawa Hospital, Ottawa, ON, Canada., Bossi P; Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy., Elad S; Oral Medicine, Eastman Institute for Oral Health, University of Rochester Medical Center, Rochester, NY, USA.

المصدر: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2024 Jul 25; Vol. 32 (8), pp. 549. Date of Electronic Publication: 2024 Jul 25.

نوع المنشور: Journal Article; Practice Guideline; Review

بيانات الدورية: Publisher: Springer International Country of Publication: Germany NLM ID: 9302957 Publication Model: Electronic Cited Medium: Internet ISSN: 1433-7339 (Electronic) Linking ISSN: 09414355 NLM ISO Abbreviation: Support Care Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Mouth Diseases*/chemically induced , Mouth Diseases*/therapy , Mouth Diseases*/etiology , Molecular Targeted Therapy*/adverse effects , Antineoplastic Agents*/adverse effects , Antineoplastic Agents*/administration & dosage, Humans ; Neoplasms/drug therapy ; Severity of Illness Index

المؤلفون: Li Q; Department of Nephrology, Blood Purification Center, Zhongshan People's Hospital, Zhongshan, China., Lin J; Department of Nephrology, Blood Purification Center, Zhongshan People's Hospital, Zhongshan, China.; Department of Nephrology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China., Hao G; Department of Nephrology, Blood Purification Center, Zhongshan People's Hospital, Zhongshan, China., Xie A; Department of Nephrology, Blood Purification Center, Zhongshan People's Hospital, Zhongshan, China., Liu S; Department of Nephrology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China., Tang B; Department of Nephrology, Blood Purification Center, Zhongshan People's Hospital, Zhongshan, China.

المصدر: Frontiers in immunology [Front Immunol] 2024 Jul 04; Vol. 15, pp. 1369118. Date of Electronic Publication: 2024 Jul 04 (Print Publication: 2024).

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Lung Neoplasms*/drug therapy , Molecular Targeted Therapy*/adverse effects , Protein Kinase Inhibitors*/adverse effects , Protein Kinase Inhibitors*/therapeutic use , Antineoplastic Agents*/adverse effects , Antineoplastic Agents*/therapeutic use, Humans ; Anaplastic Lymphoma Kinase/antagonists & inhibitors ; ErbB Receptors/antagonists & inhibitors ; Animals ; Kidney Diseases/chemically induced ; Kidney/drug effects ; Kidney/pathology ; Kidney/metabolism ; Carcinoma, Non-Small-Cell Lung/drug therapy

المؤلفون: Lu Q; Department of Biotherapy, State Key Laboratory of Biotherapy and Cancer Center, Research Unit of Gene and Immunotherapy, Chinese Academy of Medical Sciences, Collaborative Innovation Center of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China., Yang D; College of Veterinary Medicine, Shaanxi Center of Stem Cells Engineering and Technology, Northwest A&F University, Yangling, 712100, China., Li H; Department of Biotherapy, State Key Laboratory of Biotherapy and Cancer Center, Research Unit of Gene and Immunotherapy, Chinese Academy of Medical Sciences, Collaborative Innovation Center of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China., Niu T; Department of Hematology, State Key Laboratory of Biotherapy and Cancer Center, Collaborative Innovation Center of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China. niuting@wchscu.cn., Tong A; State Key Laboratory of Biotherapy and Cancer Center, Research Unit of Gene and Immunotherapy, Chinese Academy of Medical Sciences, Collaborative Innovation Center of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China. aipingtong@scu.edu.cn.; Frontiers Medical Center, Tianfu Jincheng Laboratory, Chengdu, 610212, China. aipingtong@scu.edu.cn.

المصدر: Molecular biomedicine [Mol Biomed] 2024 Jul 04; Vol. 5 (1), pp. 25. Date of Electronic Publication: 2024 Jul 04.

نوع المنشور: Journal Article; Review; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Springer Singapore Country of Publication: Singapore NLM ID: 9918283581406676 Publication Model: Electronic Cited Medium: Internet ISSN: 2662-8651 (Electronic) Linking ISSN: 26628651 NLM ISO Abbreviation: Mol Biomed Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/drug therapy , Multiple Myeloma*/therapy , Multiple Myeloma*/pathology , Multiple Myeloma*/metabolism , Signal Transduction*/drug effects , Molecular Targeted Therapy*/methods, Humans ; Animals ; Antineoplastic Agents/therapeutic use ; Antineoplastic Agents/pharmacology ; Tumor Microenvironment/drug effects

المؤلفون: Imyanitov EN; Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, St.-Petersburg, Russia.; Department of Medical Genetics, St.-Petersburg Pediatric Medical University, St.-Petersburg, Russia., Mitiushkina NV; Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, St.-Petersburg, Russia., Kuligina ES; Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, St.-Petersburg, Russia., Tiurin VI; Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, St.-Petersburg, Russia., Venina AR; Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, St.-Petersburg, Russia.

المصدر: Expert opinion on therapeutic targets [Expert Opin Ther Targets] 2024 Jul; Vol. 28 (7), pp. 613-622. Date of Electronic Publication: 2024 Jul 04.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 101127833 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7631 (Electronic) Linking ISSN: 14728222 NLM ISO Abbreviation: Expert Opin Ther Targets Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/pathology , Proto-Oncogene Proteins B-raf*/genetics , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics , Lung Neoplasms*/pathology , Mutation* , Protein Kinase Inhibitors*/pharmacology , Molecular Targeted Therapy* , Drug Resistance, Neoplasm* , Antineoplastic Agents*/pharmacology, Humans ; Animals ; MAP Kinase Signaling System/drug effects

المؤلفون: Abdalla AS; Department of Internal Medicine, AdventHealth, Sebring, Florida, USA., Rahman M; Department of Pathology, Stanford University, Stanford, CA, USA., Khan SA; Division of Oncology, Department of Medicine and Stanford Cancer Institute, Stanford University, 780 Welch Road, CJ250L, Stanford, CA, 94304, USA. Dr.Saad.Khan@Stanford.edu.

المصدر: Current treatment options in oncology [Curr Treat Options Oncol] 2024 Jul; Vol. 25 (7), pp. 869-884. Date of Electronic Publication: 2024 Jun 12.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Current Science, Inc Country of Publication: United States NLM ID: 100900946 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-6277 (Electronic) Linking ISSN: 15346277 NLM ISO Abbreviation: Curr Treat Options Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Thyroid Carcinoma, Anaplastic*/therapy , Thyroid Carcinoma, Anaplastic*/diagnosis , Thyroid Carcinoma, Anaplastic*/drug therapy , Thyroid Carcinoma, Anaplastic*/pathology , Molecular Targeted Therapy* , Neoplasm Recurrence, Local*/drug therapy, Humans ; Biomarkers, Tumor ; Disease Management ; Mutation ; Thyroid Neoplasms/therapy ; Thyroid Neoplasms/drug therapy ; Thyroid Neoplasms/diagnosis ; Thyroid Neoplasms/pathology ; Neoplasm Metastasis ; Treatment Outcome ; Disease Susceptibility

المؤلفون: López E; Department of Dermatology, Facultad de Medicina Universidad del Desarrollo-Clínica Alemana de Santiago, Santiago, Chile., Cabrera R; Department of Dermatology, Facultad de Medicina Universidad del Desarrollo-Clínica Alemana de Santiago, Santiago, Chile. Electronic address: rcabrera237@gmail.com., Lecaros C; Department of Dermatology, Facultad de Medicina Universidad del Desarrollo-Clínica Alemana de Santiago, Santiago, Chile.

المصدر: Anais brasileiros de dermatologia [An Bras Dermatol] 2024 Jul-Aug; Vol. 99 (4), pp. 546-567. Date of Electronic Publication: 2024 Mar 22.

نوع المنشور: Journal Article; Systematic Review

بيانات الدورية: Publisher: Elsevier España, S.L Country of Publication: Spain NLM ID: 0067662 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1806-4841 (Electronic) Linking ISSN: 03650596 NLM ISO Abbreviation: An Bras Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Molecular Targeted Therapy* , Skin Diseases*/drug therapy, Humans ; Antibodies, Monoclonal/therapeutic use ; Dermatologists ; Janus Kinase Inhibitors/therapeutic use